India's Strides Pharma Science drops after FDA observations for US facility

Strides Pharma Science

26/12/2025 06:28

** Shares of Strides Pharma Science  SRID.NS fall as much as 2.1% to 918.8 rupees

** Drugmaker said after market close on Wednesday it had received four observations from U.S. FDA for its New York facility

** Facility gets Form 483 - a notice of violations or issues found in co's practices or products, indicating non-compliance with regulations

** Stock up ~40% YTD, outperforming leading pharma stocks' .NIPHARM 3% decline this year

(Reporting by Nandan Mandayam in Bengaluru)

((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))